Skip to main content
Premium Trial:

Request an Annual Quote

MiraiBio to Distribute Gentra s Autopure Nucleic Acid Purification System in US


This article has been corrected from a previous version to reflect the proper locations of the companies. GenomeWeb regrets the error.


NEW YORK, Aug. 29 (GenomeWeb News) - MiraiBio, an Alameda, Calif-based unit of Hitachi Software Engineering, has signed a multi-year deal to distribute Gentra Systems' Autopure LS automated large sample nucleic acid purification system and related consumables in the US and other American territories, the companies said today.


The companies added that customers requiring manual preparation of samples will be recommended other purification products from Minneapolis-based Gentra.


Specific terms of the arrangement were not disclosed.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.